Fascin expression was reported in high percentage (87.8%) of TNBC as compared to the other breast cancer subtypes [13] and thus has been proposed as a diagnostic marker for TNBC and potential therapeutic target [13,14,15]. This evidence concerns the gene FSCN1 and breast cancer.